Cochrane Abstracts
Cannabinoids for Tourette's Syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cannabinoids for Tourette's Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette's_Syndrome.
Cannabinoids for Tourette's Syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette's_Syndrome. Accessed December 5, 2024.
Cannabinoids for Tourette's Syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette's_Syndrome
Cannabinoids for Tourette's Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette's_Syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cannabinoids for Tourette's Syndrome
ID - 435810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435810/all/Cannabinoids_for_Tourette's_Syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
